Does the leapfrog program help identify high-quality hospitals?

Joint Commission Journal on Quality and Patient Safety

Volumn 34, Issue 6, 2008, Pages 318-325

  Jha, Ashish K ^a,b   Orav, E John ^c   Ridgway, Abigail B ^a   Zheng, Jie ^d   Epstein, Arnold M ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH INSURANCE; HOSPITAL; HOSPITAL INFORMATION SYSTEM; HUMAN; INTENSIVE CARE; SAFETY; STANDARD; TREATMENT OUTCOME; UNITED STATES;

EVIDENCE-BASED MEDICINE; HOSPITALS; HUMANS; INSURANCE, HEALTH; INTENSIVE CARE; MEDICAL ORDER ENTRY SYSTEMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; SAFETY MANAGEMENT; UNITED STATES;

EID: 44449117058     PISSN: 15537250     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1553-7250(08)34040-9     Document Type: Article

References (16)

1. McGlynn E.A., et al.: The quality of health care delivered to adults in the United States. N Engl J Med 348:2635-2645, Jun. 2003.
2. Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press, 2001.
3. Milstein A., et al.: Improving the safety of health care: The Leapfrog Initiative. Eff Clin Pract 3:313-316, Nov.-Dec. 2000.
4. Galvin R.S., et al.: Has the Leapfrog Group had an impact on the health care market? Health Aff (Millwood) 24:228-233, Jan.-Feb. 2005.
5. Bates D.W., et al.: Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280:1311-1316, Oct. 21, 1998.
6. Pronovost P.J., et al.: Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 281:1310-1317, Apr. 14, 1999.
7. Dudley R.A., et al.: Selective referral to high-volume hospitals: Estimating potentially avoidable deaths. JAMA 283:1159-1166, Mar. 1, 2000.
8. Jha A.K., et al.: Care in U.S. hospitals: The Hospital Quality Alliance Program. N Engl J Med 353:265-274, Jul. 21, 2005.
9. Kahn C.N. 3rd, et al.: Snapshot of hospital quality reporting and pay-for-performance under Medicare. Health Aff (Millwood) 25:149-162, Jan.-Feb. 2006.
10. Elixhauser A., et al.: Comorbidity measures for use with administrative data. Med Care 36:8-27, Jan. 1998.
11. Christian C.K., et al.: The Leapfrog volume criteria may fall short in identifying high-quality surgical centers. Ann Surg 238:447-455; discussion 455-457, Oct. 2003.
12. Birkmeyer J.D., Dimick J.B.: Potential benefits of the new Leapfrog standards: Effect of process and outcomes measures. Surgery 135:569-575, Jun. 2004.
13. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2:349-360, Aug. 13, 1988.
14. Metoprolol in acute myocardial infarction: Patient population. The MIAMI Trial Research Group. Am J Cardiol 56:10G-14G, Nov. 22, 1985.
15. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med 329:1615-1622, Nov. 25, 1993. Erratum in: N Engl J Med 330:516, Feb. 17, 1994.
16. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 336:1621-1628, Jun. 5, 1997. Erratum in: N Engl J Med 337:287, Jul. 24, 1997.